AI-generated summary
The authors reviewed published PubMed studies of photobiomodulation (low-level laser therapy) for musculoskeletal disorders and osteoarthritis, focusing on growth over time, wavelengths used, and treated joints. They report that the field has expanded over the past 20 years and that there is no consensus on the best parameters for a given condition. They describe growing evidence of efficacy and an almost total lack of side effects, while noting gaps in knowledge.
- Who or what was studied
- Patients with musculoskeletal disorders and osteoarthritis (MSDs/OA), as studied in published literature
- Limits stated in the abstract
- The abstract does not report how many studies were included, and it notes no consensus on treatment parameters and uncertainty about molecular mechanisms.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Osteoarthritis, Photobiomodulation therapy, Low-level laser therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.